https://www.taxtmi.com/caselaws?id=1112 The Tribunal upheld the approval of price lists for pharmaceutical products manufactured on a loan license basis, finding no evidence of related persons under the Central Excise Act, 1944 between the manufacturing and selling companies. The alleged pricing discrepancy was deemed unjustified, with the Commissioner (Appeals) dismissing the Revenue's appeal due to lack of substantial evidence to alter the approved prices. The judgment emphasized the requirement for supporting evidence to modify accepted prices and affirmed the importance of assessing assessable value in such transactions. en-us Thu, 19 Oct 2006 00:00:00 +0530 Mon, 14 Apr 2008 06:25:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=1112 The Tribunal upheld the approval of price lists for pharmaceutical products manufactured on a loan license basis, finding no evidence of related persons under the Central Excise Act, 1944 between the manufacturing and selling companies. The alleged pricing discrepancy was deemed unjustified, with the Commissioner (Appeals) dismissing the Revenue's appeal due to lack of substantial evidence to alter the approved prices. The judgment emphasized the requirement for supporting evidence to modify accepted prices and affirmed the importance of assessing assessable value in such transactions. Case-Laws Central Excise Thu, 19 Oct 2006 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=1112